This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services National Institutes of Health, to Metabolon, Inc., a self-certified small disadvantaged business, for other functions metabolic analyses of art samples. The potential value of the contract is $51,060.00, with a completion date of October 31, 2017. Metabolon is a leading provider of metabolomics solutions, offering analytical methods...
This is a firm fixed price purchase order contract awarded to Metabolon, Inc., a small disadvantaged business, by the Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute. The $279,378 contract is to provide metabolomics services to support the GENEFORECAST, SIT, and MHGRID research projects. Metabolon is an experienced provider of specialized metabolomics analysis capabilities for the federal government, having supported numerous...
This is a $9,800 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Metabolon, Inc., a self-certified small disadvantaged business. The contract supports specialized metabolomics analysis services for various research programs, including those focused on veteran health, precision medicine, and environmental health impacts. Metabolon has been awarded multiple prime contracts and...
This is a $226,695.00 firm fixed price purchase order awarded by the Northeast Area division of a civilian federal agency to Metabolon, Inc., a small disadvantaged business, for metabolomic profiling of plasma samples. The contract has a period of performance through May 15, 2024. Metabolon is a leading provider of metabolomics solutions and has served as a prime contractor on numerous federal contracts, supporting research initiatives across agencies like the VA, NIH, FDA, DoD, EPA, and USDA....
This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Metabolon, Inc., a self-certified small disadvantaged business. The $15,000.00 contract is for the collection and analysis of 48 24-hour urine samples from a low-calorie-low-fat (LCLF) diet intervention study. Metabolon, a leading provider of metabolomics services, will leverage its proprietary analytical platforms to identify and quantify metabolites...
This is a firm fixed price purchase order contract awarded by the National Institutes of Health (NIH) National Institute on Aging to Metabolon, Inc., a self-certified small disadvantaged business, to provide metabolomics analysis services for the Baltimore Longitudinal Study on Aging (BLSA). The $680,800 contract will support the measurement of global plasma metabolites and targeted short-chain fatty acids in BLSA samples over a period of performance ending on June 2, 2025. Metabolon, a...
This firm fixed price purchase order contract was awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Metabolon, Inc., a self-certified small disadvantaged business. The $124,800 contract is for a project titled "The Effect of Pre-Analytical Conditions on Metabolite Stability in Urine." Metabolon is a leading provider of metabolomics solutions and has served as both a prime contractor and subcontractor on...
This is a firm-fixed price purchase order awarded by the National Institutes of Health's National Human Genome Research Institute to Metabolon, Inc., a small disadvantaged business, for the purpose of discovering diabetes metabolomics biomarkers in plasma and tissue samples from the NHGRI Fusion cohort clinical study, including meta-analysis with the METSIM cohort. The potential value of the contract is USD 376,105.00, with a completion date of May 29, 2019. Metabolon is a provider of...
This is a firm fixed-price delivery order contract awarded to Metabolon, Inc., a self-certified small disadvantaged business, by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH). The contract, valued at $12,000.00, is for a pilot study to analyze bile acid and short-chain fatty acid panels. This work supports the NCI's Metabolomic Profiling for Molecular Epidemiology Studies program, which leverages advanced metabolomics techniques to gain insights into...
This federal contract award to Metabolon, Inc., a self-certified small disadvantaged business, was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The $9,000 firm fixed-price purchase order does not have a set-aside designation. Metabolon is a leading provider of metabolomics solutions, offering advanced analytical methods and software for biomarker discovery in drug development and life sciences research. This award...